PAP mRNA transcripts | Control mRNA transcripts | ||||||
---|---|---|---|---|---|---|---|
Patients | ACPP-001 | ACPP-002 | ACPP-003 | ACPP-004 | β-actin | KLK3-201 | |
1 | X | X | X | X | |||
2 | X | X | X | X | X | X | |
3 | X | X | X | X | X | ||
4 | X | X | X | X | X | ||
5 | X | X | |||||
6 | X | X | X | X | X | ||
Non-Responders | 7 | X | X | X | X | ||
8 | X | X | X | X | |||
10 | X | X | X | ||||
11 | X | X | X | X | X | X | |
12 | X | X | X | X | X | ||
13 | X | ||||||
14 | X | X | X | X | X | ||
15 | X | X | X | X | X | ||
16 | X | X | X | X | |||
17 | X | X | X | X | X | X | |
18 | X | X | X | X | |||
19 | X | X | X | X | X | ||
24 | X | X | X | ||||
Immune Responders | 25 | X | X | ||||
26 | X | X | |||||
27 | X | X | X | X | X | X | |
28 | X | X | X | X | |||
29 | X | X | X | X | X | ||
31 | X | X | X | X | |||
32 | X | X | X | X | |||
33 | X | X | X | X | X | X |
Shown are native and alternative splice variant PAP products detected among immune non-responding patients (top, 1–13) and immune responding patients (bottom, 14–33). Detection of an mRNA transcript is indicated by an X.